- Report
- March 2024
- 186 Pages
Global
From €3205EUR$3,374USD£2,757GBP
€3562EUR$3,749USD£3,064GBP
- Report
- November 2023
- 175 Pages
Global
From €4750EUR$5,000USD£4,086GBP
- Report
- November 2023
- 150 Pages
Global
From €4608EUR$4,850USD£3,964GBP
- Drug Pipelines
- April 2024
- 230 Pages
Global
From €2850EUR$3,000USD£2,452GBP
- Report
- May 2024
- 94 Pages
Global
From €5320EUR$5,600USD£4,577GBP
- Report
- May 2024
- 93 Pages
Global
From €5320EUR$5,600USD£4,577GBP
- Report
- January 2024
- 285 Pages
Global
From €9025EUR$9,500USD£7,764GBP
- Report
- February 2024
- 115 Pages
Global
From €4513EUR$4,750USD£3,882GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1900EUR$2,000USD£1,634GBP
- Report
- January 2024
- 142 Pages
Global
From €4513EUR$4,750USD£3,882GBP
- Report
- October 2023
- 178 Pages
Global
From €4655EUR$4,900USD£4,005GBP
- Report
- March 2024
- 195 Pages
Global
From €3205EUR$3,374USD£2,757GBP
€3562EUR$3,749USD£3,064GBP
- Report
- March 2024
- 185 Pages
Global
From €3205EUR$3,374USD£2,757GBP
€3562EUR$3,749USD£3,064GBP
- Report
- March 2024
- 189 Pages
Global
From €3205EUR$3,374USD£2,757GBP
€3562EUR$3,749USD£3,064GBP
- Report
- February 2024
- 175 Pages
Global
From €4750EUR$5,000USD£4,086GBP
- Report
- May 2024
- 898 Pages
Global
From €5320EUR$5,600USD£4,577GBP
- Report
- March 2024
- 30 Pages
Global
From €2613EUR$2,750USD£2,247GBP
- Report
- March 2024
- 30 Pages
Global
From €3088EUR$3,250USD£2,656GBP
- Report
- March 2024
- 30 Pages
Global
From €3088EUR$3,250USD£2,656GBP
- Report
- March 2024
- 30 Pages
Global
From €3088EUR$3,250USD£2,656GBP
The Parkinson Drug market is a subset of the Central Nervous System Drugs market, which includes drugs used to treat neurological disorders. Parkinson's Disease is a progressive neurological disorder that affects movement, and is caused by a lack of dopamine in the brain. Parkinson Drugs are used to treat the symptoms of the disease, and can include levodopa, dopamine agonists, monoamine oxidase inhibitors, and catechol-O-methyltransferase inhibitors. These drugs can help to improve motor function, reduce tremors, and improve quality of life.
The Parkinson Drug market is highly competitive, with many companies offering a range of treatments. Some of the major players in the market include AbbVie, GlaxoSmithKline, Merck, Novartis, Pfizer, and Teva Pharmaceuticals. Show Less Read more